Selectis Health, Inc.
GBCS
$2.20
-$0.05-2.22%
| Weiss Ratings | GBCS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | GBCS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Weak | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | GBCS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -2.52 | |||
| Price History | GBCS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 0.00% | |||
| 30-Day Total Return | 0.00% | |||
| 60-Day Total Return | 22.22% | |||
| 90-Day Total Return | 29.41% | |||
| Year to Date Total Return | 76.00% | |||
| 1-Year Total Return | 10.00% | |||
| 2-Year Total Return | -50.00% | |||
| 3-Year Total Return | -69.95% | |||
| 5-Year Total Return | 15.79% | |||
| 52-Week High % Change | -12.00% | |||
| 52-Week Low % Change | 96.43% | |||
| Price | GBCS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $2.50 | |||
| 52-Week Low Price | $1.12 | |||
| 52-Week Low Price (Date) | Dec 31, 2024 | |||
| 52-Week High Price (Date) | May 09, 2024 | |||
| Valuation | GBCS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 6.75M | |||
| Enterprise Value | 38.67M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -1.80 | |||
| Earnings Per Share Growth | 114.97% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 0.18 | |||
| Price/Book (Q) | -1.20 | |||
| Enterprise Value/Revenue (TTM) | 1.01 | |||
| Price | $2.20 | |||
| Enterprise Value/EBITDA (TTM) | -9.70 | |||
| Enterprise Value/EBIT | -6.87 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | GBCS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 3.07M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | $0.10 | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | 0.00% | |||
| Dividend Per Share (Most Recent) | $0.10 | |||
| Company Info | GBCS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 720 680 0808 | |||
| Address | 8480 E. Orchard Road Greenwood Village, CO 80111-5006 | |||
| Website | www.selectis.com | |||
| Country | United States | |||
| Year Founded | 1978 | |||
| Profitability | GBCS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -14.68% | |||
| Profit Margin | -14.31% | |||
| Management Effectiveness | GBCS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -9.22% | |||
| Return on Equity | -- | |||
| Income Statement | GBCS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 480.20K | |||
| Total Revenue (TTM) | 38.30M | |||
| Revenue Per Share | $12.49 | |||
| Gross Profit (TTM) | 8.06M | |||
| EBITDA (TTM) | -3.99M | |||
| EBIT (TTM) | -5.63M | |||
| Net Income (TTM) | -5.48M | |||
| Net Income Avl. to Common (TTM) | -5.48M | |||
| Total Revenue Growth (Q YOY) | 10.73% | |||
| Earnings Growth (Q YOY) | 28.96% | |||
| EPS Diluted (TTM) | -1.80 | |||
| EPS Diluted Growth (Q YOY) | 29.16% | |||
| Balance Sheet | GBCS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 984.40K | |||
| Cash Per Share (Q) | $0.32 | |||
| Total Current Assets (Q) | 3.53M | |||
| Total Preferred Equity (Q) | 0.78 | |||
| Total Equity (Q) | -4.83M | |||
| Current Ratio (Q) | 0.175 | |||
| Book Value Per Share (Q) | -$1.83 | |||
| Total Assets (Q) | 33.93M | |||
| Total Current Liabilities (Q) | 20.20M | |||
| Total Debt (Q) | 32.13M | |||
| Total Liabilities (Q) | 38.76M | |||
| Total Common Equity (Q) | -5.61M | |||
| Cash Flow | GBCS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | 2.46M | |||
| Cash from Financing (TTM) | -450.20K | |||
| Net Change in Cash (TTM) | -1.25M | |||
| Levered Free Cash Flow (TTM) | 235.90K | |||
| Cash from Operations (TTM) | -3.26M | |||
